MRD / Regn No. : 20260000315 Date : 22/07/2026
Patient Name : Punam Saha Age & Gender : 36 Yrs. / Female
Contact No. : 9831731751 UHID :
Ht / Wt / BMI : 161 / 76 / 29.32 BP S / BP D : /
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (15/Apr/2026) | OBESITY (15/Apr/2026) | OBESITY WITH METABOLIC COMPLICATIONS (15/Apr/2026) | VITAMIN D DEFICIENCY (15/Apr/2026) |
Subjective : HX OF GDM,POST GDM RECURRENCE OF DM,DYSESTHESIAS,HAS STOPPED MEDICATIONS
Objective : NONE
Analysis : OBESITY,TYPE 2 DM,VITAMIN D DEFICIENCY
Plan : INCREASE MOUNJARO 5 MG,SEE ME IN 2 MONTHS WITH TESTING  
Salient Investigations : TOTAL CHOLESTEROL: 194.97 mg/dl | FASTING PLASMA GLUCOSE (FPG): 111.72 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 139.31 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 CAPSULE CHOLECALCIFEROL 2000 IU
D RISE
Medicine For VITAMIN D 		PO 0-0-1 AT BEDTIME
 TILL NEXT VISIT
2 INJECTION TIRZEPATIDE 5 MG
MOUNJARO
Medicine For OBESITY DIABETES 		SQ ONCE A WEEK AS DIRECTED NO RELATION TO FOOD
 TILL NEXT VISIT
MAY CAUSE NAUSEA VOMITING OR DIARRHEA
       
Refill : 0 / Substitution:    
Education : RARE VERY RARE INSTANCES OF EYE DISTURBANCE WITH TIRZEPATIDE HAVE BEEN REPORTED
Next Visit : 21/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP HBA1C
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: